Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Neurology · Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

What Questions Should I Ask a Neurologist About CADASIL?

At a Glance

Choosing a CADASIL neurologist is easier when you ask about experience with rare small-vessel disease, MRI and genetic test interpretation, stroke prevention and blood pressure control, migraine care, and collaboration with neurogenetics specialists.

Finding a neurologist who understands CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is an important step in managing your care. Because CADASIL is a rare disease, many general neurologists may only see a few cases in their career. You can evaluate a neurologist’s experience by asking targeted questions about their approach to blood pressure monitoring, stroke prevention, migraine management, and genetic test interpretation.

Understanding Your CADASIL Care Needs

CADASIL is a genetic disorder caused by mutations in the NOTCH3 gene, which leads to vessel-wall degeneration in small cerebral arteries and subsequent white-matter injury in the brain [1]. While there is no proven disease-modifying cure, care involves much more than just treating isolated symptoms. Comprehensive management includes addressing conventional vascular risks (like smoking, diabetes, and cholesterol), coordinating physical rehabilitation, and supporting cognitive and mood health [2][3].

Because of these complexities, a local neurologist can often manage your ongoing care, but consulting with a specialized neurogenetics center or a stroke neurologist with expertise in rare monogenic small-vessel diseases can be very helpful [4][1]. They can assist with uncertain genetic results, difficult medication decisions, and family counseling while coordinating with your local doctor.

Urgent Stroke Symptoms

Because CADASIL increases the risk of stroke, and migraine aura can sometimes overlap with stroke symptoms, you need a clear emergency plan. Seek emergency medical help immediately—do not wait for a specialist appointment—if you or a loved one experience:

  • Sudden facial droop, weakness, or numbness
  • Sudden trouble speaking or understanding speech
  • Sudden vision loss or changes
  • Severe, unexplained loss of balance or coordination
  • A new, unusually severe headache

Questions to Ask a New Neurologist

1. “How do you evaluate and monitor CADASIL on an MRI?”

Why you should ask this: A doctor familiar with the condition will know that classic MRI findings include changes in the anterior temporal poles and external capsule, though these are not present in every patient [5]. They will also understand how to use susceptibility-sensitive MRI sequences to identify cerebral microbleeds (tiny areas of past bleeding in the brain) [6]. An experienced neurologist will interpret these scans in the context of your symptoms and history to guide individualized treatment, rather than relying on a rigid, fixed scanning schedule.

2. “How do you approach antiplatelet and anticoagulant medications for stroke prevention?”

Why you should ask this: CADASIL involves ischemic strokes (caused by damage or blockage in small brain arteries) as well as a risk for brain bleeds [4][7]. There is no universal daily antiplatelet (like aspirin) regimen for asymptomatic CADASIL patients. Furthermore, anticoagulants (stronger blood thinners used for other conditions like atrial fibrillation) carry different bleeding profiles. An experienced neurologist will carefully weigh the potential benefits of these medications against your personal microbleed burden and overall health [8][6]. You should never start or stop these medications without consulting your doctor.

3. “What is my individualized blood pressure target?”

Why you should ask this: Careful blood pressure control is a cornerstone of CADASIL management [2]. High blood pressure is strongly associated with an increased risk of intracerebral hemorrhage, and some observational studies suggest this risk may be especially relevant for patients with specific NOTCH3 variants, such as the R544C mutation [7][9]. However, there is no single “CADASIL-specific” blood pressure number. Your doctor should set an individualized target based on standard hypertension guidelines, your kidney and cardiovascular health, and your specific symptoms [4].

4. “How will we weigh the risks and benefits of migraine treatments?”

Why you should ask this: Migraines, often with aura, are a common feature of CADASIL [1]. Standard treatments often include triptans or other vasoconstrictive medications (drugs that narrow blood vessels). Because CADASIL affects brain blood vessels, the use of triptans requires a careful, individualized risk-benefit discussion; they are not universally banned, but caution is advised [10]. Alternatives, such as CGRP inhibitors, have shown promise in small case reports, but they also lack robust, long-term safety data in CADASIL [11]. An experienced specialist will discuss these uncertainties and help you build a personalized migraine plan.

The Role of Genetic Counseling

If you have questions about your genetic test results, a neurogenetics center can be invaluable. For instance, they can help interpret a Variant of Uncertain Significance (VUS). A VUS means a genetic change was found, but it is not definitively clear if it causes the disease. A VUS should not be used as proof of CADASIL or to make medical decisions on its own [12].

Furthermore, if a clearly pathogenic (disease-causing) NOTCH3 mutation is confirmed, genetic counselors can discuss cascade testing for your adult relatives [13]. Because CADASIL is inherited in an autosomal dominant pattern, each child of an affected parent has a 50% chance of inheriting the mutation, though symptoms and onset age can vary [14]. Counseling ensures families understand the medical, emotional, and insurance implications before making family-testing decisions.

Common questions in this guide

What can I ask to judge a neurologist’s experience with CADASIL?
Ask how many people with CADASIL or related inherited small-vessel diseases the neurologist has treated, how they keep up with recommendations, and when they involve a specialized center. A local neurologist may coordinate routine care, while a neurogenetics or stroke specialist can help with complex MRI, medication, or genetic questions.
What should an experienced CADASIL neurologist look for on an MRI?
An experienced neurologist will look for characteristic white-matter changes, including involvement of the anterior temporal poles and external capsule, and may use MRI sequences that show tiny old brain bleeds. The findings should be interpreted with your symptoms and history rather than by following a rigid scan schedule.
Does everyone with CADASIL need aspirin or another blood thinner?
Not necessarily. There is no universal daily antiplatelet plan for people without symptoms, and stronger blood thinners may carry different bleeding risks. The decision should account for your reason for treatment, MRI findings, blood pressure, and overall health; do not start or stop a blood thinner without medical advice.
How is a safe blood pressure goal chosen for someone with CADASIL?
CADASIL does not have one blood pressure number that fits everyone. Your target should be based on usual blood pressure guidance and your kidney health, heart and blood-vessel health, and individual symptoms. Regular monitoring helps your clinician adjust the plan.
Are migraine medicines such as triptans safe with CADASIL?
Triptans are not automatically forbidden in CADASIL, but because they narrow blood vessels, their risks and benefits should be reviewed individually. CGRP-targeted medicines may be an option, although long-term safety information in CADASIL is limited. Ask the neurologist to help create a personalized migraine plan.
When should I see a neurogenetics center or genetic counselor?
A neurogenetics center or genetic counselor can help when a genetic result is unclear, especially when a result is called a variant of uncertain significance; that result alone should not prove CADASIL or guide treatment. If a disease-causing NOTCH3 mutation is confirmed, counseling can explain family testing, including the 50% chance for each child of an affected parent, while recognizing that symptoms can vary.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with CADASIL or other monogenic small-vessel diseases have you managed, and how do you stay current on care guidelines?
  2. 2.Under what specific circumstances would you recommend an antiplatelet, an anticoagulant, or neither, given my MRI results?
  3. 3.What is my individualized blood pressure goal, and how will we monitor it?
  4. 4.How do you evaluate the risks and benefits of triptans versus CGRP inhibitors for my migraines?
  5. 5.What conventional vascular risks—such as cholesterol or diabetes—should we be prioritizing in my care plan?
  6. 6.When would it be helpful for me to consult a specialized neurogenetics center or a genetic counselor?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association.

    Meschia JF, Worrall BB, Elahi FM, et al.

    Stroke 2023; (54(10)):e452-e464 doi:10.1161/STR.0000000000000444.

    PMID: 37602377
  2. 2

    Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.

    Chabriat H, Hervé D, Duering M, et al.

    Stroke 2016; (47(1)):4-11 doi:10.1161/STROKEAHA.115.010696.

    PMID: 26578659
  3. 3

    Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL): A Rare Cause of Transient Ischemic Attack.

    Ashraf S, Allena N, Shrestha E, et al.

    Cureus 2022; (14(10)):e30940 doi:10.7759/cureus.30940.

    PMID: 36465750
  4. 4

    Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.

    Mancuso M, Arnold M, Bersano A, et al.

    European journal of neurology 2020; (27(6)):909-927 doi:10.1111/ene.14183.

    PMID: 32196841
  5. 5

    CADASIL: Imaging Characteristics and Clinical Correlation.

    Zhu S, Nahas SJ

    Current pain and headache reports 2016; (20(10)):57 doi:10.1007/s11916-016-0584-6.

    PMID: 27591799
  6. 6

    Cerebral Microbleed Burdens in Specific Brain Regions Are Associated With Disease Severity of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.

    Chung CP, Chen JW, Chang FC, et al.

    Journal of the American Heart Association 2020; (9(13)):e016233 doi:10.1161/JAHA.120.016233.

    PMID: 32552418
  7. 7

    Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?

    Chen CH, Cheng YW, Zhang R, et al.

    Stroke 2025; (56(8)):2159-2166 doi:10.1161/STROKEAHA.124.050484.

    PMID: 40270244
  8. 8

    R558C NOTCH3 Mutation in a CADASIL Patient with Intracerebral Hemorrhage: A Case Report with Literature Review.

    Hu L, Liu G, Fan Y

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2022; (31(7)):106541 doi:10.1016/j.jstrokecerebrovasdis.2022.106541.

    PMID: 35523050
  9. 9

    Pro-Hemorrhagic Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Associated with NOTCH3 p.R75P Mutation with Low Vascular NOTCH3 Aggregation Property.

    Ishiyama H, Kim H, Saito S, et al.

    Annals of neurology 2024; (95(6)):1040-1054 doi:10.1002/ana.26916.

    PMID: 38520151
  10. 10

    Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports.

    Albanese M, Pescini F, Di Bonaventura C, et al.

    Journal of clinical medicine 2024; (13(7)) doi:10.3390/jcm13071870.

    PMID: 38610637
  11. 11

    Genetic migraine disorders and the response to calcitonin gene-related peptide antagonist treatment.

    Kuczynski AM, Kingston WS

    Headache 2025; (65(6)):1041-1043 doi:10.1111/head.14942.

    PMID: 40341526
  12. 12

    CADASIL or NOTCH3 mutaion spectrum diseases? Interpretation of NOTCH3 mutations and clinical heterogeneity in CADASIL.

    Wang Y, Liu Y, Mo H, et al.

    Frontiers in neurology 2025; (16()):1662012 doi:10.3389/fneur.2025.1662012.

    PMID: 41018180
  13. 13

    Genetic diagnosis of CADASIL in three Hong Kong Chinese patients: A novel mutation within the intracellular domain of NOTCH3.

    Hung LY, Ling TK, Lau NKC, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2018; (56()):95-100 doi:10.1016/j.jocn.2018.06.050.

    PMID: 29980472
  14. 14

    Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management.

    Guey S, Lesnik Oberstein SAJ, Tournier-Lasserve E, Chabriat H

    Stroke 2021; (52(9)):3025-3032 doi:10.1161/STROKEAHA.121.032620.

    PMID: 34399586

This page provides general information about choosing a neurologist for CADASIL and does not replace medical advice. Discuss your MRI findings, medications, blood pressure goals, migraine treatment, and genetic results with your healthcare team.

Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.